Suppression of type I interferon production by human T-cell leukemia virus type 1 oncoprotein Tax through inhibition of IRF3 phosphorylation

Journal of Virology

Volumn 90, Issue 8, 2016, Pages 3902-3912

  Yuen, Chun Kit ^a   Chan, Ching Ping ^a   Fung, Sin Yee ^a   Wang, Pei Hui ^a   Wong, Wan Man ^a   Tang, Hei Man Vincent ^a   Yuen, Kit San ^a   Chan, Chi Ping ^a   Jin, Dong Yan ^a   Kok, Kin Hang ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; CYCLIC AMP; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; I KAPPA B KINASE EPSILON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON; INTERFERON REGULATORY FACTOR 3; INTERFERON REGULATORY FACTOR 7; MESSENGER RNA; RETINOIC ACID INDUCIBLE PROTEIN I; TAX PROTEIN; CREB1 PROTEIN, HUMAN; IRF3 PROTEIN, HUMAN; PROTEIN SERINE THREONINE KINASE; TBK1 PROTEIN, HUMAN;

AMINO TERMINAL SEQUENCE; ARTICLE; BINDING SITE; COCULTURE; CONTROLLED STUDY; DIMERIZATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; HUMAN T-LYMPHOTROPIC VIRUS 1; IMMUNOPRECIPITATION; INNATE IMMUNITY; INTERFERON PRODUCTION; LONG TERMINAL REPEAT; PLASMID; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SENDAI VIRUS; T LYMPHOCYTE; VIRUS INHIBITION; VIRUS REPLICATION; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CELL LINE; GENETICS; HEK293 CELL LINE; JURKAT CELL LINE; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; T CELL LEUKEMIA; VIROLOGY;

CELL LINE; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; GENE PRODUCTS, TAX; HEK293 CELLS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; INTERFERON REGULATORY FACTOR-3; INTERFERON-BETA; JURKAT CELLS; LEUKEMIA-LYMPHOMA, ADULT T-CELL; NF-KAPPA B; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; T-LYMPHOCYTES;

EID: 84963838293     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00129-16     Document Type: Article

References (66)

1. Bazarbachi A, Suarez F, Fields P, Hermine O. 2011. How I treat adult T-cell leukemia/lymphoma. Blood 118:1736-1745. http://dx.doi.org/10.1182/blood-2011-03-345702.
2. Ishitsuka K, Tamura K. 2014. Human T-cell leukaemia virus type I and adult T-cell leukaemia-lymphoma. Lancet Oncol 15:e517-e526. http://dx.doi.org/10.1016/S1470-2045(14)70202-5.
3. Gill PS, Harrington W, Jr, Kaplan MH, Ribeiro RC, Bennett JM, Liebman HA, Bernstein-Singer M, Espina BM, Cabral L, Allen S, Kornblau S, Pike MC, Levine AM. 1995. Treatment of adult T-cell leukemia-lymphoma with a combination of interferon α and zidovudine. N Engl J Med 332:1744-1748. http://dx.doi.org/10.1056/NEJM199506293322603.
4. Hermine O, Bouscary D, Gessain A, Turlure P, Leblond V, Franck N, Buzyn-Veil A, Rio B, Macintyre E, Dreyfus F, Bazarbachi A. 1995. Treatment of adult T-cell leukemia-lymphoma with zidovudine and interferon α. N Engl J Med 332:1749-1751. http://dx.doi.org/10.1056/NEJM199506293322604.
5. Samuel CE. 2001. Antiviral actions of interferons. Clin Microbiol Rev 14:778-809. http://dx.doi.org/10.1128/CMR.14.4.778-809.2001.
6. González-Navajas JM, Lee J, David M, Raz E. 2012. Immunomodulatory functions of type I interferons. Nat Rev Immunol 12:125-135. http://dx.doi.org/10.1038/nri3133.
7. Kagan JC, Barton GM. 2014. Emerging principles governing signal transduction by pattern-recognition receptors. Cold Spring Harb Perspect Biol 7:a016253. http://dx.doi.org/10.1101/cshperspect.a016253.
8. Yoneyama M, Onomoto K, Jogi M, Akaboshi T, Fujita T. 2015. Viral RNA detection by RIG-I-like receptors. Curr Opin Immunol 32:48-53. http://dx.doi.org/10.1016/j.coi.2014.12.012.
9. Dempsey A, Bowie AG. 2015. Innate immune recognition of DNA: a recent history. Virology 479-480:146-152. http://dx.doi.org/10.1016/j.virol.2015.03.013.
10. Schneider WM, Chevillotte MD, Rice CM. 2014. Interferon-stimulated genes: a complex web of host defenses. Annu Rev Immunol 32:513-545. http://dx.doi.org/10.1146/annurev-immunol-032713-120231.
11. Berg RK, Melchjorsen J, Rintahaka J, Diget E, Søby S, Horan KA, Gorelick RJ, Matikainen S, Larsen CS, Ostergaard L, Paludan SR, Mogensen TH. 2012. Genomic HIV RNA induces innate immune responses through RIG-I-dependent sensing of secondary-structured RNA. PLoS One 7:e29291. http://dx.doi.org/10.1371/journal.pone.0029291.
12. Kok KH, Lui PY, Ng MHJ, Siu KL, Au SWN, Jin DY. 2011. The double-stranded RNA-binding protein PACT functions as a cellular activator of RIG-I to facilitate innate antiviral response. Cell Host Microbe 9:299-309. http://dx.doi.org/10.1016/j.chom.2011.03.007.
13. Gao D, Wu J, Wu YT, Du F, Aroh C, Yan N, Sun L, Chen ZJ. 2013. Cyclic GMP-AMP synthase is an innate immune sensor of HIV and other retroviruses. Science 341:903-906. http://dx.doi.org/10.1126/science.1240933.
14. Yoh SM, Schneider M, Seifried J, Soonthornvacharin S, Akleh RE, Olivieri KC, De Jesus PD, Ruan C, de Castro E, Ruiz PA, Germanaud D, des Portes V, García-Sastre A, König R, Chanda SK. 2015. PQBP1 is a proximal sensor of the cGAS-dependent innate response to HIV-1. Cell 161:1293-1305. http://dx.doi.org/10.1016/j.cell.2015.04.050.
15. Sun L, Wu J, Du F, Chen X, Chen ZJ. 2013. Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science 339:786-791. http://dx.doi.org/10.1126/science.1232458.
16. Cai X, Chiu YH, Chen ZJ. 2014. The cGAS-cGAMP-STING pathway of cytosolic DNA sensing and signaling. Mol Cell 54:289-296. http://dx.doi.org/10.1016/j.molcel.2014.03.040.
17. Mankan AK, Schmidt T, Chauhan D, Goldeck M, Höning K, Gaidt M, Kubarenko AV, Andreeva L, Hopfner KP, Hornung V. 2014. Cytosolic RNA:DNAhybrids activate the cGAS-STING axis.EMBOJ 33:2937-2946. http://dx.doi.org/10.15252/embj.201488726.
18. Versteeg GA, García-Sastre A. 2010. Viral tricks to grid-lock the type I interferon system. Curr Opin Microbiol 13:508-516. http://dx.doi.org/10.1016/j.mib.2010.05.009.
19. Randall RE, Goodbourn S. 2008. Interferons and viruses: an interplay between induction, signaling, antiviral responses and virus countermeasures. J Gen Virol 89:1-47. http://dx.doi.org/10.1099/vir.0.83391-0.
20. Journo C, Mahieux R. 2011. HTLV-1 and innate immunity. Viruses 3:1374-1394. http://dx.doi.org/10.3390/v3081374.
21. van Montfoort N, Olagnier D, Hiscott J. 2014. Unmasking immune sensing of retroviruses: interplay between innate sensors and host effectors. Cytokine Growth Factor Rev 25:657-668. http://dx.doi.org/10.1016/j.cytogfr.2014.08.006.
22. Olière S, Hernandez E, Lézin A, Arguello M, Douville R, Nguyen TL, Olindo S, Panelatti G, Kazanji M, Wilkinson P, Sékaly RP, Césaire R, Hiscott J. 2010. HTLV-1 evades type I interferon antiviral signaling by inducing the suppressor of cytokine signaling 1 (SOCS1). PLoS Pathog 6:e1001177. http://dx.doi.org/10.1371/journal.ppat.1001177.
23. Charoenthongtrakul S, Zhou Q, Shembade N, Harhaj NS, Harhaj EW. 2011. Human T cell leukemia virus type 1 Tax inhibits innate antiviral signaling via NF-κB-dependent induction of SOCS1. J Virol 85:6955-6962. http://dx.doi.org/10.1128/JVI.00007-11.
24. Kashanchi F, Brady JN. 2005. Transcriptional and posttranscriptional gene regulation of HTLV-1. Oncogene 24:5938-5951. http://dx.doi.org/10.1038/sj.onc.1208973.
25. Grassmann R, Aboud M, Jeang KT. 2005. Molecular mechanisms of cellular transformation by HTLV-1 Tax. Oncogene 24:5976-5985. http://dx.doi.org/10.1038/sj.onc.1208978.
26. Boxus M, Twizere JC, Legros S, Dewulf JF, Kettmann R, Willems L. 2008. The HTLV-1 Tax interactome. Retrovirology 5:76. http://dx.doi.org/10.1186/1742-4690-5-76.
27. Zhao LJ, Giam CZ. 1992. Human T-cell lymphotropic virus type I (HTLV-I) transcriptional activator, Tax, enhances CREB binding to HTLV-I 21-base-pair repeats by protein-protein interaction. Proc Natl Acad SciUSA89:7070-7074. http://dx.doi.org/10.1073/pnas.89.15.7070.
28. Semmes OJ, Jeang KT. 1995. Definition of a minimal activation domain in human T-cell leukemia virus type I Tax. J Virol 69:1827-1833.
29. Ching YP, Chun AC, Chin KT, Zhang ZQ, Jeang KT, Jin DY. 2004. Specific TATAA and bZIP requirements suggest that HTLV-I Tax has transcriptional activity subsequent to the assembly of an initiation complex. Retrovirology 1:18. http://dx.doi.org/10.1186/1742-4690-1-18.
30. Siu YT, Chin KT, Siu KL, Choy EYW, Jeang KT, Jin DY. 2006. TORC1 and TORC2 coactivators are required for Tax activation of the human T-cell leukemia virus type 1 long terminal repeats. J Virol 80:7052-7059. http://dx.doi.org/10.1128/JVI.00103-06.
31. Ballard DW, Böhnlein E, Lowenthal JW, Wano Y, Franza BR, Greene WC. 1988. HTLV-I Tax induces cellular proteins that activate the κB element in the IL-2 receptor α gene. Science 241:1652-1655. http://dx.doi.org/10.1126/science.2843985.
32. Leung K, Nabel GJ. 1988. HTLV-1 transactivator induces interleukin-2 receptor expression through an NF-κB-like factor. Nature 333:776-778. http://dx.doi.org/10.1038/333776a0.
33. Ruben S, Poteat H, Tan TH, Kawakami K, Roeder R, Haseltine W, Rosen CA. 1988. Cellular transcription factors and regulation of IL-2 receptor gene expression by HTLV-I Tax gene product. Science 241:89-92. http://dx.doi.org/10.1126/science.2838905.
34. Chan JK, Greene WC. 2012. Dynamic roles for NF-κB in HTLV-I and HIV-1 retroviral pathogenesis. Immunol Rev 246:286-310. http://dx.doi.org/10.1111/j.1600-065X.2012.01094.x.
35. Hyun J, Ramos JC, Toomey N, Balachandran S, Lavorgna A, Harhaj E, Barber GN. 2015. Oncogenic human T-cell lymphotropic virus type 1 Tax suppression of primary innate immune signaling pathways. J Virol 89: 4880-4893. http://dx.doi.org/10.1128/JVI.02493-14.
36. Suzuki S, Zhou Y, Refaat A, Takasaki I, Koizumi K, Yamaoka S, Tabuchi Y, Saiki I, Sakurai H. 2010. Human T cell lymphotropic virus 1 manipulates interferon regulatory signals by controlling the TAK1-IRF3ε and IRF4 pathways. J Biol Chem 285:4441-4446. http://dx.doi.org/10.1074/jbc.M109.031476.
37. Diani E, Avesani F, Bergamo E, Cremonese G, Bertazzoni U, Romanelli MG. 2015. HTLV-1 Tax protein recruitment into IKKe and TBK1 kinase complexes enhances IFN-I expression. Virology 476:92-99. http://dx.doi.org/10.1016/j.virol.2014.12.005.
38. Chan CP, Siu YT, Kok KH, Ching YP, Tang HMV, Jin DY. 2013. Group I p21-activated kinases facilitate Tax-mediated transcriptional activation of the human T-cell leukemia virus type 1 long terminal repeats. Retrovirology 10:47. http://dx.doi.org/10.1186/1742-4690-10-47.
39. Tang HMV, Gao WW, Chan CP, Siu YT, Wong CM, Kok KH, Ching YP, Takemori H, Jin DY. 2013. LKB1 tumor suppressor and saltinducible kinases negatively regulate human T-cell leukemia virus type 1 transcription. Retrovirology 10:40. http://dx.doi.org/10.1186/1742-4690-10-40.
40. Kew C, Lui PY, Chan CP, Liu X, Au SWN, Mohr I, Jin DY, Kok KH. 2013. Suppression of PACT-induced type I interferon production by herpes simplex virus 1 Us11 protein. J Virol 87:13141-13149. http://dx.doi.org/10.1128/JVI.02564-13.
41. Tang HMV, Gao WW, Chan CP, Cheng Y, Chaudhary V, Deng JJ, Yuen KS, Wong CM, Ng IOL, Kok KH, Zhou J, Jin DY. 2014. Requirement of CRTC1 coactivator for hepatitis B virus transcription. Nucleic Acids Res 42:12455-12468. http://dx.doi.org/10.1093/nar/gku925.
42. Siu KL, Kok KH, Ng MHJ, Poon VKM, Yuen KY, Zheng BJ, Jin DY. 2009. Severe acute respiratory syndrome coronavirus M protein inhibits type I interferon production by impeding the formation of TRAF3·TANK·TBK1/IKKe complex. J Biol Chem 284:16202-16209. http://dx.doi.org/10.1074/jbc.M109.008227.
43. Siu KL, Chan CP, Woo PCY, Jin DY. 2014. Comparative analysis of the activation of unfolded protein response by spike proteins of severe acute respiratory syndrome coronavirus and human coronavirus HKU1. Cell Biosci 4:3. http://dx.doi.org/10.1186/2045-3701-4-3.
44. Siu KL, Chan CP, Kok KH, Woo PCY, Jin DY. 2014. Suppression of innate antiviral response by severe acute respiratory syndrome coronavirusMprotein is mediated through the first transmembrane domain. Cell Mol Immunol 11:141-149. http://dx.doi.org/10.1038/cmi.2013.61.
45. Zhu FX, King SM, Smith EJ, Levy DE, Yuan Y. 2002. A Kaposi's sarcoma-associated herpesviral protein inhibits virus-mediated induction of type I interferon by blocking IRF-7 phosphorylation and nuclear accumulation. Proc Natl Acad Sci U S A 99:5573-5578. http://dx.doi.org/10.1073/pnas.082420599.
46. Jin DY, Spencer F, Jeang KT. 1998. Human T-cell leukemia virus type I oncoprotein Tax targets the human mitotic checkpoint protein MAD1. Cell 93:81-91. http://dx.doi.org/10.1016/S0092-8674(00)81148-4.
47. Jin DY, Giordano V, Kibler KV, Nakano H, Jeang KT. 1999. Role of adapter function in oncoprotein-mediated activation of NF-κB: human T-cell leukemia virus type I Tax interacts directly with IκB kinase γ. J Biol Chem 274:17402-17405.
48. Siu YT, Ching YP, Jin DY. 2008. Activation of TORC1 transcriptional coactivator through MEKK1-induced phosphorylation. Mol Biol Cell 19: 4750-4761. http://dx.doi.org/10.1091/mbc.E08-04-0369.
49. Strahle L, Garcin D, Kolakofsky D. 2006. Sendai virus defectiveinterfering genomes and the activation of interferon-β. Virology 351:101-111. http://dx.doi.org/10.1016/j.virol.2006.03.022.
50. Ho TH, Kew C, Lui PY, Chan CP, Satoh T, Akira S, Jin DY, Kok KH. 2016. PACT-and RIG-I-dependent activation of type I interferon production by a defective-interfering RNA in measles virus vaccine. J Virol 90: 1557-1568. http://dx.doi.org/10.1128/JVI.02161-15.
51. Igakura T, Stinchcombe JC, Goon PK, Taylor GP, Weber JN, Griffiths GM, Tanaka Y, Osame M, Bangham CR. 2003. Spread of HTLV-I between lymphocytes by virus-induced polarization of the cytoskeleton. Science 299:1713-1716. http://dx.doi.org/10.1126/science.1080115.
52. Sharma S, tenOever BR, Grandvaux N, Zhou GP, Lin R, Hiscott J. 2003. Triggering the interferon antiviral response through an IKK-related pathway. Science 300:1148-1151. http://dx.doi.org/10.1126/science.1081315.
53. McWhirter SM, Fitzgerald KA, Rosains J, Rowe DC, Golenbock DT, Maniatis T. 2004. IFN-regulatory factor 3-dependent gene expression is defective in Tbk1-deficient mouse embryonic fibroblasts. Proc Natl Acad Sci U S A 101:233-238. http://dx.doi.org/10.1073/pnas.2237236100.
54. Zhong B, Yang Y, Li S, Wang YY, Li Y, Diao F, Lei C, He X, Zhang L, Tien P, Shu HB. 2008. The adaptor protein MITA links virus-sensing receptors to IRF3 transcription factor activation. Immunity 29:538-550. http://dx.doi.org/10.1016/j.immuni.2008.09.003.
55. Liu S, Cai X, Wu J, Cong Q, Chen X, Li T, Du F, Ren J, Wu YT, Grishin NV, Chen ZJ. 2015. Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation. Science 347:aaa2630. http://dx.doi.org/10.1126/science.aaa2630.
56. Lin R, Heylbroeck C, Pitha PM, Hiscott J. 1998. Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential, and proteasome-mediated degradation. Mol Cell Biol 18:2986-2996. http://dx.doi.org/10.1128/MCB.18.5.2986.
57. Smith MR, Greene WC. 1990. Identification of HTLV-I Tax transactivator mutants exhibiting novel transcriptional phenotypes. Genes Dev 4:1875-1885. http://dx.doi.org/10.1101/gad.4.11.1875.
58. Semmes OJ, Jeang KT. 1992. Mutational analysis of human T-cell leukemia virus type I Tax: regions necessary for function determined with 47 mutant proteins. J Virol 66:7183-7192.
59. Pomerantz JL, Baltimore D. 1999. NF-κB activation by a signaling complex containing TRAF2, TANK and TBK1, a novel IKK-related kinase. EMBO J 18:6694-6704. http://dx.doi.org/10.1093/emboj/18.23.6694.
60. Fitzgerald KA, McWhirter SM, Faia KL, Rowe DC, Latz E, Golenbock DT, Coyle AJ, Liao SM, Maniatis T. 2003. IKKe and TBK1 are essential components of the IRF3 signaling pathway. Nat Immunol 4:491-496. http://dx.doi.org/10.1038/ni921.
61. Au WC, Moore PA, Lowther W, Juang YT, Pitha PM. 1995. Identification of a member of the interferon regulatory factor family that binds to the interferon-stimulated response element and activates expression of interferon-induced genes. Proc Natl Acad SciUSA92:11657-11661. http://dx.doi.org/10.1073/pnas.92.25.11657.
62. Sze A, Belgnaoui SM, Olagnier D, Lin R, Hiscott J, van Grevenynghe J. 2013. Host restriction factor SAMHD1 limits human T cell leukemia virus type 1 infection of monocytes via STING-mediated apoptosis. Cell Host Microbe 14:422-434. http://dx.doi.org/10.1016/j.chom.2013.09.009.
63. Chu ZL, Shin YA, Yang JM, DiDonato JA, Ballard DW. 1999. IKKγ mediates the interaction of cellular IκB kinases with the tax transforming protein of human T cell leukemia virus type 1. J Biol Chem 274:15297-15300. http://dx.doi.org/10.1074/jbc.274.22.15297.
64. Harhaj EW, Sun SC. 1999. IKKγ serves as a docking subunit of the IκB kinase (IKK) and mediates interaction of IKK with the human T-cell leukemia virus Tax protein. J Biol Chem 274:22911-22914. http://dx.doi.org/10.1074/jbc.274.33.22911.
65. Chiang C, Beljanski V, Yin K, Olagnier D, Ben Yebdri F, Steel C, Goulet ML, DeFilippis VR, Streblow DN, Haddad EK, Trautmann L, Ross T, Lin R, Hiscott J. 2015. Sequence-specific modifications enhance the broad-spectrum antiviral response activated by RIG-I agonists. J Virol 89:8011-8025. http://dx.doi.org/10.1128/JVI.00845-15.
66. Sali TM, Pryke KM, Abraham J, Liu A, Archer I, Broeckel R, Staverosky JA, Smith JL, Al-Shammari A, Amsler L, Sheridan K, Nilsen A, Streblow DN, DeFilippis VR. 2015. Characterization of a novel human-specific STING agonist that elicits antiviral activity against emerging alphaviruses. PLoS Pathog 11:e1005324. http://dx.doi.org/10.1371/journal.ppat.1005324.